Tradfi
Sectors
Sentiment
Injective vs CME Group — crypto-native derivatives L1 vs the world's largest derivatives exchange. Market cap and product overlap.
| Metric | Injective | CME Group | Δ |
|---|---|---|---|
| Injective Market Cap | $365.50M | — | — |
| Injective Price | $3.65 | — | — |
| Injective 24h Change | +0.73% | — | — |
| Injective FDV | $365.50M | — | +0.0% |
| Injective ATH | $52.62 | — | — |
Crypto data live from Sharpe's tracker cache; TradFi values are reference benchmarks updated quarterly.
CME Group's market cap has ranged $75B-$110B in 2024-2026 as the dominant US derivatives exchange, handling $1T+ daily notional across futures and options on interest rates, equity indices, energy, metals, and — increasingly — BTC/ETH futures. Injective's market cap ($1.5B-$5B) is 1.5-7% of CME. The comparison is pure sector: Injective is a crypto-native L1 purpose-built for on-chain derivatives and orderbook-based trading, with native support for perpetuals, options, and prediction markets. CME is the centralized incumbent with ~200 years of institutional pedigree. Injective has partnered with Binance and has live on-chain perpetuals via Helix. Correlation near zero; CME trades on rate-volatility cycles, INJ on crypto-derivatives TVL.
Side-by-side crypto comparison with normalized returns
Rolling correlation between crypto and major TradFi benchmarks